SIB-1553A
Names
[ CAS No. ]:
191611-89-9
[ Name ]:
SIB-1553A
[Synonym ]:
Phenol, 4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]-, hydrochloride (1:1)
4-{[2-(1-Methyl-2-pyrrolidinyl)ethyl]sulfanyl}phenol hydrochloride (1:1)
Biological Activity
[Description]:
SIB-1553A hydrochloride is an orally bioavailable nicotinic acetylcholine receptors (nAChRs) agonist, with selectivity for β4 subunit-containing nAChRs. SIB-1553A hydrochloride is also a selective neuronal nAChR ligand. SIB-1553A hydrochloride is a cognitive enhancer, and has therapeutic potential for the symptomatic treatment of Alzheimer’s disease and other cognitive disorders[1][2].
[Related Catalog]:
[In Vitro]
SIB-1553A hydrochloride displaces the binding of [H]nicotine (NIC) to the rat brain nAChRs with an IC50 value of 110 nM[1]. In calcium flux assays, SIB-1553A hydrochloride (0.1-5 μM), shows a greater selectivity for beta4-subunit containing recombinant hnAChRs (alpha2beta4, alpha3beta4 and alpha4beta4) vs. beta2-subunit containing nAChRs (alpha4beta2 and alpha3beta2) both in terms of efficacy and potency[2].
[In Vivo]
SIB-1553A hydrochloride (1-40 mg/kg; s.c.) produces dose-dependent increases in ACh levels[3]. Animal Model: Male Sprague-Dawley rats (200-250 g)[3] Dosage: 1, 2, 4, 10, 20 and 40 mg/kg Administration: s.c. Result: Induced hippocampal ACh release.
[References]
Chemical & Physical Properties
[ Molecular Formula ]:
C13H20ClNOS
[ Molecular Weight ]:
273.822
[ Exact Mass ]:
273.095398